Table 1.

RabGTPase alterations in cancer are frequently associated with the hallmarks of cancer invasion and metastasis.

Brain	Lung	Bladder
Organs/RabGTPasesRab3 [101], Rab27 [102], Rab35 [32],	Rab6 [103], Rab11 [104], Rab35 [78], Rab37 [105],	(Rab11, Rab20, Rab23, Rab27) [106], Rab25 [107],
Breast
Rab2 [108], Rab4 [109], Rab5 [110–112], Rab6 [113,114], Rab11 [115],
Rab25 [116–118], Rab27 [119–121], Rab31 [122,123], Rab35 [32,39,74], Rab40 [124],
Esophagus	Colon/rectus		Stomach
Rab25 [125],	Rab1 [126], Rab3 [127], Rab5 [128], Rab25 [129],		Rab23 [130], Rab40 [131],
Liver		Pancreas
(Rab1, Rab4, Rab10, Rab22, Rab24, Rab25) [132], Rab5 [133], Rab23 [134], Rab27 [135],		Rab20 [136],
Cervix	Ovary	Prostate	Kidney
Rab5 [137], Rab35 [76],	Rab25 [116,138], Rab35 [72]	Rab7 [139], Rab25 [140]	Rab25 [141],
Skin		Blood
Rab7 [142], Rab11 [132], Rab35 [32],		Rab2 [143,144],
		Rab4 [145],
Tongue	Head, neck and oral squamous cell carcinoma		Mesothelioma
Rab1 [146]	(Rab5, Rab7, Rab11) [147], Rab25 [148,149],		Rab7 [138]

Superscripts refer to reference. The table shows reports of RabGTPase alterations in different organs and tissues, many of which were reported to be related with metastasis.